PharmGen Science

KSC:004720 · KR7004720009

PharmaceuticalsSmall

360

Medium confidence — indicative

Value57

Profit price6

Cash yield35

Owner Earnings Yield69

Dividend Yield1

Sales & asset price87

Price/Sales70

EV / Gross Profit97

Price/Book95

Quality54

Returns on capital67

Return on Capital74

Cash Return on Capital67

Return on Equity60

Profit margins74

EBIT Margin74

Gross Profitability74

Cash backing33

Cash Conversion1

Owner Earnings Margin64

Growth—

Sales growth62

Profit growth1

Reinvestment42

Price momentum21

Safety73

Debt load78

Debt serviceability75

Refinancing94

Debt Payback56

Liquidity50

Sentiment41

Analyst ratings—

Expectations trend—

Market mood73

Profile

CountrySouth Korea

IndustryPharmaceuticals

SizeSmall

TypePublic Company

ExchangeKOSE

Founded1966

Websitepharmgenscience.com

ISINKR7004720009

Last UpdateApr 2, 2026

Indices

KOSPI (South Korea)

Themes

Health Diagnostics

Description

Analysis

Middle-of-the-road

PharmGen Science, Inc. sits in the middle of our grid: average quality, average price, no obvious signal in either direction. Worth noting: the cash the business generates has lagged behind what the income statement shows.

On valuation, the picture is attractive. The owner-earnings multiple stands at 14.5×; owner earnings: the cash an owner could take out each year.

Growth is mixed; the safety picture is sturdy.

Flags to be aware of: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250

2026

All-time high

Jun 2026

All-time low

Mar 2026

Average rank

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023

Price/Sales

—

Price/Earnings

—

Price/Book

—

Dividend Yield

—

Value (overall)

—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare PharmGen Science with its peers

Kukje Pharma

KSC:002720

CountrySouth Korea

IndustryPharmaceuticals

SizeSmall

Full Stock Analysis →

Samsung Pharm

KSC:001360

—

CountrySouth Korea

IndustryPharmaceuticals

SizeSmall

Full Stock Analysis →

Hana Pharm

KSC:293480

CountrySouth Korea

IndustryPharmaceuticals

SizeSmall

Full Stock Analysis →

Reyon Pharmaceutical

KSC:102460

CountrySouth Korea

IndustryPharmaceuticals

SizeSmall

Full Stock Analysis →

Korea United Pharm

KSC:033270

CountrySouth Korea

IndustryPharmaceuticals

SizeSmall

Full Stock Analysis →

Pulmuone Corporate

KSC:017810

CountrySouth Korea

IndustryFood Products

SizeMedium

Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View

1 · Watch OutGood· 100

Value

1 · ExpensiveGood Value· 100

Quality

1 · Weak FundamentalsHigh Quality· 100

Growth

1 · Tough TimesHigh Growth· 100

Safety

1 · High LeverageWell-Financed· 100

Sentiment

1 · SkepticismPositive· 100

Learn More →